Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...